Role of thromboxane A2 receptor on the effects of oxidized LDL on microvascular endothelium nitric oxide, endothelin-1, and IL-6 production

Microcirculation

Volumn 15, Issue 6, 2008, Pages 543-553

  Lubrano, Valter ^a   Baldi, Simona ^b   Ferrannini, Ele ^a,b   L'Abbate, Antonio ^c   Natali, Andrea ^b  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c SCUOLA SUPERIORE SANT ANNA   (Italy)

Author keywords

Endothelins; Endothelium; Lipoproteins; Microcirculation; Nitric oxide

Indexed keywords

7 [3 [(4 PHENYLSEMICARBAZIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; 8 ISOPROSTAGLANDIN F2 ALPHA; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; INTERLEUKIN 6; NITRATE; NITRIC OXIDE; NITRITE; OXIDIZED LOW DENSITY LIPOPROTEIN; THROMBOXANE A2 RECEPTOR; IL6 PROTEIN, HUMAN; LOW DENSITY LIPOPROTEIN; NOS3 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MICROCIRCULATION; MICROVASCULARIZATION; OXIDATION; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN FUNCTION; VASCULAR ENDOTHELIUM; BIOSYNTHESIS; CELL CULTURE; CYTOLOGY; DOSE RESPONSE; METABOLISM;

CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; ENDOTHELIN-1; HUMANS; INTERLEUKIN-6; LIPOPROTEINS, LDL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; OXIDATION-REDUCTION; RECEPTORS, THROMBOXANE A2, PROSTAGLANDIN H2;

EID: 49249118773     PISSN: 10739688     EISSN: 15498719     Source Type: Journal    
DOI: 10.1080/10739680701884765     Document Type: Article

References (41)

1. Abarquez Jr., R. F. (2003) Microvascular disease relevance in the hypertension syndrome. Clin Hemorheol Microcirc, 29, pp. 295-300.
2. Ades, E. W., Candal, F. J., Swerlick, R. A., George, V. G., Summers, S., Bosse, D. C. and Lawley, T. J. (1992) HMEC-1: Establishment of an immortalized human microvascular endothelial cell line. J Invest Dermatol, 99, pp. 683-690.
3. Ashton, A. W., Cheng, Y., Helisch, A. and Ware, J. A. (2004) Thromboxane A2 receptor agonists antagonize the proangiogenic effects of fibroblast growth factor-2: Role of receptor internalization, thrombospondin-1, and alpha(v)beta-3. Circ Res, 94, pp. 735-742.
4. Assaloni, R., Da Ros, R., Quagliaro, L., Piconi, L., Maier, A., Zuodar, G., Motz, E. and Ceriello, A. (2005) Effects of S21403 (mitiglinide) on postprandial generation of oxidative stress and inflammation in type 2 diabetic patients. Diabetologia, 48, pp. 1919-1924.
5. Bloodsworth, A., O'Donnell, V. B. and Freeman, B. A. (2000) Nitric oxide regulation of free-radical- and enzyme-mediated lipid and lipoprotein oxidation. Arterioscler Thromb Vasc Biol, 20, pp. 1707-1715.
6. Boulanger, C. M., Tanner, F. C., Bea, M. L., Hahn, A. W., Werner, A. and Luscher, T. F. (1992) Oxidized low-density lipoproteins induce mRNA expression and release of endothelin from human and porcine endothelium. Circ Res, 70, pp. 1191-1197.
7. Cominacini, L., Rigoni, A., Pasini, A. F., Garbin, U., Davoli, A., Campagnola, M., Pastorino, A. M., Lo Cascio, V and Sawamura, T. (2001) The binding of oxidized low density lipoprotein (ox-LDL) to Ox-LDL receptor-1 reduces the intracellular concentration of nitric oxide in endothelial cells through an increased production of superoxide. J Biol Chem, 276, pp. 13750-13755.
8. Cracowski, J. L., Devillier, P., Durand, T., Stanke-Labesque, F. and Bessard, G. (2001) Vascular biology of the isoprostanes. J Vasc Res, 38, pp. 93-103.
9. Esterbauer, H. and Cheeseman, K. (1990) Determination of aldehyde lipid peroxidation products: Malonaldehyde and 4-hydroxinonenal. Meth Enzymol, 186, pp. 407-421.
10. Fleming, I., Mohamed, A., Galle, J., Turchanowa, L., Brandes, R. P., Fisslthaler, B. and Busse, R. (2005) Oxidized low-density lipoprotein increases superoxide production by endothelial nitric oxide synthase by inhibiting PKCalpha. Cardiovasc Res, 65, pp. 897-906.
11. Freyschuss, A., Xiu, R. J., Zhang, J., Ying, X., Diczfalusy, U., Jogestrand, T., Henriksson, P. and Bjorkhem, I. (1997) Vitamin C reduces cholesterol-induced microcirculatory changes in rabbits. Arterioscler Thromb Vasc Biol, 17, pp. 1178-1184.
12. Go, Y. M., Levonen, A. L., Moellering, D., Ramachandran, A., Patel, R. P., Jo, H. and Darley-Usmar, V. M. (2001) Endothelial NOS-dependent activation of c-Jun NH(2)-terminal kinase by oxidized low-density lipoprotein. Am J Physiol Heart Circ Physiol, 281, pp. H2705-H2713.
13. Green, L., Wagner, D., Glogowski, J., Skipper, P., Wishnok, J. and Tannenbaum, S. (1982) Analysis of nitrite, nitrate, and [15N]nitrate in biological fluids. Anal Biochem, 126, pp. 131-138.
14. He, Z. and King, G. L. (2004) Microvascular complications of diabetes. Endocrinol Metab Clin North Am, 33, pp. 215-238.
15. Hirata, K., Niki, N., Kuroda, Y., Sakoca, T., Kawashima, S. and Yokoyama, M. (1995) Low concentration of oxidised low-density lipoprotein and lysophosphatdylcholine upregulate constitutive nitric-oxide synthase mRNA expression in bovine aortic endothelial cells. Circ Res, 76, pp. 958-962.
16. Horio, T., Kohno, M., Yasunari, K., Murakawa, K., Yokokawa, K., Ikeda, M., Fukui, T. and Takeda, T. (1993) Stimulation of endothelin-1 release by low-density and very-low-density lipoproteins in cultured human endothelial cells. Atherosclerosis, 101, pp. 185-190.
17. Hulthe, J. and Fagerberg, B. (2002) Circulating oxidized LDL is associated with subclinical atherosclerosis development and inflammatory cytokines (AIR Study). Arterioscler Thromb Vasc Biol, 22, pp. 1162-1167.
18. Itabe, H. and Ueda, M. (2007) Measurement of plasma oxidized low-density lipoprotein and its clinical implications. J Atheroscler Thromb, 14, pp. 1-11.
19. Khan, M., Pelengaris, S., Cooper, M., Smith, C., Evan, G. and Betteridge, J. (2003) Oxidised lipoproteins may promote inflammation through the selective delay of engulfment but not binding of apoptotic cells by macrophages. Atherosclerosis, 171, pp. 21-29.
20. Kumar, A., Kingdon, E. and Norman, J. (2005) The isoprostane 8-iso-PGF2 alpha suppresses monocyte adhesion to human microvascular endothelial cells via two independent mechanisms. Faseb J, 19, pp. 443-445.
21. Liao, K., Shin, W., Lee, W. and Clark, S. (1995) Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase. J Biol Chem, 270, pp. 319-324.
22. Lu, Q., Bjorkhem, I., Wretlind, B., Diczfalusy, U., Henriksson, P. and Freyschuss, A. (2005) Effect of ascorbic acid on microcirculation in patients with Type II diabetes: A randomized, placebo-controlled, cross-over study. Clin Sci (Lond), 108, pp. 507-513.
23. Lubrano, V., Vassalle, C., Blandizzi, C., Del Tacca, M, Palombo, C., L'Abbate, A., Baldi, S. and Natali, A. (2003) The effect of lipoproteins on endothelial nitric oxide synthase is modulated by lipoperoxides. Eur J Clin Invest, 33, pp. 117-125.
24. Ma, F. X., Zhou, B., Chen, Z., Ren, Q., Lu, S. H., Sawamura, T. and Han, Z. C. (2006) Oxidized low density lipoprotein impairs endothelial progenitor cells by regulation of endothelial nitric oxide synthase. J Lipid Res, 47, pp. 1228-1237.
25. Mehta, J. L., Li, D. Y., Chen, H. J., Joseph, J. and Romeo, F. (2001) Inhibition of LOX-1 by statins may regulate to upregulation of eNOS. Biochem Ciophys Res Commun, 289, pp. 857-861.
26. Morris Jr., S. M. and Billiar, T. R. (1994) New insights into the regulation of inducible nitric oxide synthesis. Am J Physiol, 266, pp. E829-E839.
27. Morrow, J. D., Hill, K. E., Burk, R. F., Nammour, T. M., Badr, K. F. and Roberts 2nd, L. J. (1990) A series of prostaglandin F2-like compounds are produced in vivo in humans by a noncyclo-oxygenase, free-radical-catalyzed mechanism. Proc Natl Acad Sci U S A, 87, pp. 9383-9387.
28. Mourad, J. J. and Laville, M. (2006) Is hypertension a tissue perfusion disorder? Implications for renal and myocardial perfusion. J Hypertens Suppl, 24, pp. S10-S16.
29. Niemann, B., Rohrbach, S., Catar, R. A., Muller, G., Barton, M. and Morawietz, H. (2005) Native and oxidized low-density lipoproteins stimulate endothelin-converting enzyme-1 expression in human endothelial cells. Biochem Biophys Res Commun, 334, pp. 747-753.
30. O'Rourke, M. F. and Safar, M. E. (2005) Relationship between aortic stiffening and microvascular disease in brain and kidney: Cause and logic of therapy. Hypertension, 46, pp. 200-204.
31. Raychowdhury, M. K., Yukawa, M., Collins, L. J., McGrail, S. H., Kent, K. C. and Ware, J. A. (1995) Alternative splicing produces a divergent cytoplasmic tail in the human endothelial thromboxane A2 receptor. J Biol Chem, 270, p. 7011.
32. Sakurai, K., Cominacini, L., Garbin, U., Fratta Pasini, A, Sasaki, N., Takuwa, Y., Masaki, T. and Sawamura, T. (2004) Induction of endothelin-1 production in endothelial cells via cooperative action between CD40 and lectin-like oxidized LDL receptor (LOX-1). J Cardiovasc Pharmacol, 44, pp. S173-S180.
33. Serne, E. H., de Jongh, R. T., Eringa, E. C., Ijzerman, R. G., de Boer, M. P. and Stehouwer, C. D. (2006) Microvascular dysfunction: Causative role in the association between hypertension, insulin resistance and the metabolic syndrome?. Essays Biochem, 42, pp. 163-176.
34. Steffan, Y., Jung, T., Klotz, L. O., Schewe, T., Grune, T. and Sies, H. (2007) Protein modification elicited by oxidized low-density lipoprotein (LDL) in endothelial cells: Protection by (-)-epicatechin. Free Radic Biol Med, 42, pp. 955-970.
35. Stepp, D. W., Ou, J., Ackerman, A. W., Welak, S., Klick, D. and Pritchard Jr., K. A. (2002) Native LDL and minimally oxidized LDL differentially regulate superoxide anion in vascular endothelium in situ. Am J Physiol Heart Circ Physiol, 283, pp. H750-H759.
36. Stokes, K., Cooper, D., Tailor, A. and Granger, D. (2002) Hypercholesterolemia promotes inflammation and microvascular dysfunction: Role of nitric oxide and superoxide. Free Radic Biol Med, 33, pp. 1026-1036.
37. Takabe, W., Kanai, Y., Chairoungdua, A., Shibata, N., Toi, S., Kobayashi, M., Kodama, T. and Noguchi, N. (2004) Lysophosphatidylcholine enhances cytokine production of endothelial cells via induction of L-type amino acid transporter 1 and cell-surface antigen 4F2. Arterioscler Thromb Vasc Biol, 24, pp. 1640-1645.
38. Tanner, F. C., Noll, G., Boulanger, C. M. and Luscher, T. F. (1991) Oxidized low-density lipoproteins inhibit relaxations of porcine coronary arteries. Role of scavenger receptor and endothelium-derived nitric oxide. Circulation, 83, pp. 2012-2020.
39. Yoshida, H., Sasaki, K., Namiki, Y., Sato, N. and Tada, N. (2005) Edaravone, a novel radical scavenger, inhibits oxidative modification of low-density lipoprotein (LDL) and reverses oxidized LDL-medicated reduction in the expression and endothelial nitric oxide synthase. Atheroschlerosis, 179, pp. 97-102.
40. Yura, T., Fukunaga, M., Khan, R., Nassar, G. N., Badr, K. F. and Montero, A. (1999) Free-radical-generated F2-isoprostane stimulates cell proliferation and endothelin-1 expression on endothelial cells. Kidney Int, 56, pp. 471-478.
41. Zmijewski, J. W., Moellering, D. R., Le Goffe, C, Landar, A., Ramachandran, A. and Darley-Usmar, V. M. (2005) Oxidized LDL induces mitochondrially associated reactive oxygen/nitrogen species formation in endothelial cells. Am J Physiol Heart Circ Physiol, 289, pp. H852-H861.